NASDAQ·US·Medical Instruments & Supplies
RMDRMD
สรุป
ปานกลาง
Today's session
ถือ
Quality and timing disagree — good company, but the trend is weak. Watch for a turn.
What investors notice
Key signs
Plain-language read of the metrics that matter most for this stock.
Strengths
- Best-in-class return on equity22%
- High return on invested capital20%
- Low ROE volatility — durable franchise1.2 pp
- Gross margin trending up
- Strong free-cash-flow compounding104%
- Net cash on the balance sheet-0.2×
- Long-term debt declining year-over-year
- Pristine fundamentals (Piotroski 7+)8/9
- ROIC well above cost of capital — value-creating14%
Risks
- Inconsistent profitability4/10
Watchlist
None detected.
1Y · period change vs 2025-04-29
Score history (10y)
How quality has trended through cycles.
Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.
Fair value range
5 of 5 models · trimmed-mean consensus
Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.
10-year financials
Annual revenue, profit, and free cash flow with year-over-year growth overlay.
YoY growth overlaid
Snapshot
At a glance
Top-line figures most investors check first.
Last updated 4/30/2026, 4:19:23 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer